SBIR/STTR Research Award

A NEW METHOD FOR STERILIZING BIOMEDICAL MATERIALS

Award identifier d865c8bb52dcb22d37d1e055cdc86abb18b122da74e0b63d45598e1b0f667506Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$95,173

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NOVASTERILIS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
HZMPWKV873R2
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Description (provided by applicant): Development of novel biomedical sterilization technology is proposed. The method utilizes supercritical C02, which allows for the sterilization of materials that are incompatible with current methods. This technology can be applied to a variety of biomedical materials, including thermally and hydrolytically sensitive polymers, as well as biopolymers. The method will find application in sterilizing numerous biomedical materials. Initial results showed complete inactivation of a variety of vegetative microorganisms, with short exposure times (0.6-4.0 h) and low temperatures (25-60 C). Attached macromolecules (proteins, nucleic acids, biodegradable drug delivery matrices) that might be damaged by existing sterilization methods have been shown to be compatible with C02. Specific aims include (1) to achieve the inactivation of bacterial spores by developing certain process modifications to improve the overall methodology; (2) to conduct a screening study to evaluate the influence of individual additives on the efficiency of sterilization; (3) to develop combinations of process modifications and additives, based on findings in Aims 1 and 2, that would inactivate high concentrations of bacterial spores. The long-term objective of this project is to develop a commercially viable sterilization method that would be compatible with emerging biomaterials and biomimetic structures and would eventually replace ethylene oxide as a sterilization method. In particular, sterilization of the new synthetic extracellular matrix, a.k.a. synthetic skin, not compatible with any other sterilization method, will be investigated in collaboration with the original inventor of the synthetic skin at the University of Utah. The new C02-based sterilization technology produces no environmentally hazardous byproducts, and should be readily transferred to biomedical industry. The commercial reactors would use C02 on closed-system basis (similar to many existing C02-based extraction systems) where used C02 would be purified and reused again (complete recycling system).

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

13 SBIR/STTR records share this UEI (2002–2024). Reported award amounts total $6,284,336. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.